ICON PLC
Nasdaq · Services-Commercial Physical & Biological Research
Company Overview
A concise company profile alongside the latest public filing activity.
ICON plc is a contract research organization that provides outsourced drug and medical device development services, including clinical trial management, data analytics, and regulatory support, to pharmaceutical, biotechnology, and medical device companies.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Grais LindaDirector | Sell | $14K | 87at $162.72 | Aug 11, 2026 |
| Grais LindaDirector | Sell | $11K | 67at $165.51 | Aug 11, 2026 |
| Clerkin Nigel Bernard JohnChief Financial Officer | Sell | $262K | 1,591at $164.47 | Aug 11, 2026 |
| CLIMAX JOHN DRDirector | Sell | $97K | 591at $164.47 | Aug 11, 2026 |
| Grais LindaDirector | Sell | $97K | 590at $164.47 | Aug 11, 2026 |
| Clerkin Nigel Bernard JohnChief Financial Officer | Sell | $42K | 259at $163.77 | Aug 11, 2026 |
| Clerkin Nigel Bernard JohnChief Financial Officer | Sell | $39K | 237at $162.72 | Aug 11, 2026 |
| Grais LindaDirector | Sell | $16K | 97at $163.77 | Aug 11, 2026 |
| CLIMAX JOHN DRDirector | Sell | $16K | 95at $163.77 | Aug 11, 2026 |
| CLIMAX JOHN DRDirector | Sell | $14K | 88at $162.72 | Aug 11, 2026 |
| Clerkin Nigel Bernard JohnChief Financial Officer | Sell | $30K | 180at $165.51 | Aug 11, 2026 |
| CLIMAX JOHN DRDirector | Sell | $11K | 67at $165.51 | Aug 11, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Kevin HernOK01 | House | Sell | $15,001 - $50,000 | Aug 14, 2026 |
| Kevin HernOK01 | House | Sell | $100,001 - $250,000 | Mar 5, 2026 |
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ICLR activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.